SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. (2014). Mediterranean Journal of Hematology and Infectious Diseases, 6(1), e2014003. https://doi.org/10.4084/mjhid.2014.003